Blood test breakthrough? new study aims to spot rare cancers earlier
NCT ID NCT06361641
First seen Jun 24, 2026 · Last updated Aug 11, 2026 · Updated 4 times
Summary
This study looks at a type of immune cell called monocytes in people with certain blood cancers (polycythemia vera, essential thrombocythemia, and myelofibrosis). Researchers will analyze blood samples from 70 newly diagnosed patients to find unique patterns in these cells. The goal is to see if these patterns can help confirm the diagnosis more accurately than current methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a new blood test that helps doctors diagnose these blood cancers more accurately and earlier.
- What could go wrong
- This is an early observational study with only 70 participants, so results may not apply to everyone. It is not testing a treatment, so it won't directly help patients yet.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL THROMBOCYTHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BESCOND Charles
NOT_YET_RECRUITINGCholet, Maine et Loire, 49325, France
-
GOUBAND Agathe
RECRUITINGAngers, Maine et Loire, 49933, France
-
TRUCHAN-GRACZYK Malgorzata
NOT_YET_RECRUITINGSaumur, Maine et Loire, 49400, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a hormone mimic curb the need for bloodletting in a blood cancer?
- Can a Dual-Action pill tame bone marrow tumors?
- Can a new pill shrink the spleen in myelofibrosis?
- Can a daily pill shrink the spleen in myelofibrosis?
- Could a platelet-boosting drug shorten recovery after stem cell transplants?
- Can a new drug reduce bloodletting for polycythemia vera?